Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectives
Pharmaceutical Science Advances · 2026-12 · 4 · 100130
DOI: 10.1016/j.pscia.2026.100130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Jiaxin Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Jiangning Chinese Medicine Hospital, China Pharmaceutical University, Nanjing, 211100, PR China. Die Arbeit nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affiliated Jiangning Chinese Medicine Hospital, China Pharmaceutical University, Nanjing, 211100, PR China.
- School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, PR China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zheng, J., Chen, W., Qin, F., Zhang, P., & Xu, F. (2026). Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectives. Pharmaceutical Science Advances, 4, 100130. https://doi.org/10.1016/j.pscia.2026.100130
Vancouver
Zheng J, Chen W, Qin F, Zhang P, Xu F. Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectives. Pharmaceutical Science Advances. 2026;4:100130. doi:10.1016/j.pscia.2026.100130
BibTeX
@article{Zheng2026,
author = {Zheng, Jiaxin and Chen, Wanting and Qin, Fengxia and Zhang, Pei and Xu, Fengguo},
title = {Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectives},
journal = {Pharmaceutical Science Advances},
year = {2026},
volume = {4},
pages = {100130},
doi = {10.1016/j.pscia.2026.100130}
}
EUVIMED